Literature DB >> 1627864

Mitral and aortic valvular flow: quantification with MR phase mapping.

L Søndergaard1, C Thomsen, F Ståhlberg, E Gymoese, K Lindvig, P Hildebrandt, O Henriksen.   

Abstract

When magnetic resonance phase mapping is used to quantitate valvular blood flow, the presence of higher-order-motion terms may cause a loss of phase information. To overcome this problem, a sequence with reduced encoding for higher-order motion was used, achieved by decreasing the duration of the flow-encoding gradient to 2.2 msec. Tested on a flow phantom simulating a severe valvular stenosis, the sequence was found to be robust for higher-order motion within the clinical velocity range. In eight healthy volunteers, mitral and aortic volume flow rates and peak velocities were quantified by means of phase mapping and compared with results of the indicator-dilution technique and Doppler echocardiography, respectively. Statistically significant correlations were found between phase mapping and the other two techniques. Similar studies in patients with valvular disease indicate that phase mapping is also valid for pathologic conditions. Phase mapping may be used as a noninvasive clinical tool for flow quantification in heart valve disease.

Entities:  

Mesh:

Year:  1992        PMID: 1627864     DOI: 10.1002/jmri.1880020308

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

Review 1.  MRI Assessment of Diastolic and Systolic Intraventricular Pressure Gradients in Heart Failure.

Authors:  Snigdha Jain; Francisco J Londono; Patrick Segers; Thierry C Gillebert; Marc De Buyzere; Julio A Chirinos
Journal:  Curr Heart Fail Rep       Date:  2016-02

Review 2.  Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management.

Authors:  Roshin C Mathew; Adrián I Löffler; Michael Salerno
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

Review 3.  Magnetic resonance imaging of acquired cardiac disease.

Authors:  C L Carrol; C B Higgins; G R Caputo
Journal:  Tex Heart Inst J       Date:  1996

Review 4.  Heart valve disease: investigation by cardiovascular magnetic resonance.

Authors:  Saul G Myerson
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-19       Impact factor: 5.364

5.  Cardiac 4D phase-contrast CMR at 9.4 T using self-gated ultra-short echo time (UTE) imaging.

Authors:  M Krämer; A G Motaal; K-H Herrmann; B Löffler; J R Reichenbach; G J Strijkers; V Hoerr
Journal:  J Cardiovasc Magn Reson       Date:  2017-03-31       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.